Table 1.
Patient characteristics (n = 9).
| Age, years (mean ±SD, range) | 63.7 ± 6.8 (55-78) |
| BMI, kg/m2 (mean ±SD, range) | 24.6 ± 6.5 (15.5-33.95) |
| Male; female, n | 7; 2 |
| ASA status, n (%) | |
|---|---|
| Grade II | 1 (11) |
| Grade III | 8 (89) |
| Grade IV | 0 (0) |
| Histology, n (%) | |
| AC | 7 (78) |
| SCC | 2 (22) |
| Benign | 0 (0) |
| Tumor location, n (%)* | |
| Proximal half of esophagus | 2 (22) |
| Distal half of esophagus | 5 (56) |
| Esophagogastric junction (Siewert II) | 2 (22) |
| Preoperative therapy, n (%)* | |
| None | 0 (0) |
| Radiochemotherapy | 3 (33) |
| Chemotherapy | 6 (67) |
| UICC stages, n (%)* | |
| I | 2 (22) |
| Ia | 1 (11) |
| Ib | 0 (0) |
| II | 0 (0) |
| IIIa | 1 (11) |
| IIIb | 3 (33) |
| IVa | 1 (11) |
| IVb | 1 (11) |
IQR, interquartile range; BMI, body mass index; ASA, American Society of Anesthesiologists; AC, adenocarcinoma; SCC, squamous cell carcinoma; UICC, Union Internationale Contre le Cancer TNM Classification for Esophageal Cancer 8th edition.
a
Patients with malignant indication n = 9.